EAE. A. Avetisyan

E. A. Avetisyan

*This is an algorithmically generated author record based on publicly available information.

E. A. Avetisyan has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Post-infarction ventricular septal rupture: short-term outcomes. Seven-year Russian single-center experience

    by E. A. Avetisyan, D. V. Pevzner, I. A. Merkulova, A. K. Alieva, L. O. Dulaev, I. T. Zyuryaev, A. D. Levshukov, E. V. Merkulov, A. G. Osiev, A. S. Tereshchenko, et al.

    Aim . To evaluate short-term clinical and procedural outcomes in patients with post-infarction ventricular septal rupture (PIVSR). Material and methods . This single-center, retrospective, non-randomized, observational cohort study included patients with PIVSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. The analysis was conducted according to the type of procedure performed. The primary endpoint was any-cause inhospital mortality, with secondary endpoints including inhospital cardiovascular mortality and the rate of technical and procedural success after curative treatment. Results . In the period 2019-2025, the study included 94 patients with PIVSR (mean age, 68,5±12 years women, 56,4%). Open surgical repair was performed in 35,1% (33/94) of patients, while percutaneous closure (PC) — in 50,0% (47/94), conservative treatment — in 12,8% (12/94), and heart transplantation or implantation of a long-term left ventricular assist device with immediate open surgical repair. Secondary open surgical repair after PC was performed in 14,9% (7/47) of patients. Cardiogenic shock occurred in 62,8% (59/94) of patients: in the open surgical repair group — in 36,4% (12/33), in the PC group — in 83% (39/47). Mechanical circulatory support was used in 53,2% (50/94) of cases. Any-cause inhospital mortality was 53,3% (49/92): 74,5% (35/47) with PC, and 21,2% (7/33) with open surgical repair, and 58,3% (7/12) with conservative treatment. In the general group, 34,8% (32/92) of patients died from cardiovascular causes. In the open surgical repair and PC groups, technical success was achieved in 97,5% and 87,2%, and procedural success — in 72,7% and 51,1%, respectively. Conclusion . Approximately half of patients with PIVSR survive to discharge with a comprehensive treatment approach. In our center’s experience, various curative treatment methods complement each other and are used in patient populations with different clinical severity. The results highlight the need for further research aimed at optimizing the strategy, specifically the choice of intervention type and timing, and the use of mechanical circulatory support.

  • Open Access

    Patient profile and clinical features of postinfarction ventricular septal rupture. Seven-year experience at a single center in Russia

    by E. A. Avetisyan, D. V. Pevzner, I. A. Merkulova, A. K. Alieva, L. O. Dulaev, I. T. Zyuryaev, A. D. Levshukov, E. V. Merkulov, A. G. Osiev, A. S. Tereshchenko, et al.

    Aim . To study the clinical and demographic data of a non-selective population of patients with post-infarction ventricular septal rupture (VSR) at a single center in Russia. Material and methods . This single-center, retrospective, observational cohort study included all patients with post-infarction VSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. Demographics, comorbidities, clinical course, echocardiographic data, frequency and timing of open surgical repair and percutaneous closure, mechanical circulatory support, and patient routing were assessed using descriptive statistics. A search for independent factors influencing the choice of primary intervention was conducted using multiple logistic regression. Results . A total of 94 patients with post-infarction VSR were included in the study between 2019 and 2025. The mean age was 68,5±12 years (women, 56,4%). The most common medical history included hypertension (82/94, 87,2%), diabetes (35/94, 37,2%) and obesity (27/94, 28,7%). An attempt of coronary reperfusion was made in 69,2% of patients (65/94), while only in 28,7% (27/94) it was timely and successful. Cardiogenic shock (CS) occurred in 66% (62/94) of cases, most often stages D 24/62 (38,7%) and E 20/62 (32,3%). Mechanical circulatory support was used in 53,2% of cases. Any curative treatment was performed in 87,2% of cases. Independent predictors of percutaneous closure were pre-intervention CS (8,31 [2,77-24,93], pConclusion . Patients with post-infarction VSR have significant comorbidity. Timely successful coronary reperfusion was achieved in less than a third of patients. A high incidence of end-stage CS is noted, which, along with age over 65,5 years, is an independent predictor of performing percutaneous closure.

  • Open Access

    Temporary mechanical circulatory support with the iVAC 2L transaortic device in high-risk percutaneous coronary intervention — a multicenter experience

    by E. A. Avetisyan, O. B. Dorogun, E. V. Krasnoperova, R. S. Tarasov, V. I. Ganyukov, A. E. Baev, L. G. Shestakova, O. L. Polonetsky, V. V. Bazylev, M. E. Evdokimov, et al.

    Aim. To analyze the multicenter international experience of high-risk protected percutaneous coronary intervention (PCI) procedures using the transaortic temporary pulsatile mechanical circulatory support (MCS) device iVAC 2L (PulseCath B. V., Amsterdam, the Netherlands).Material and methods. The pilot prospective-retrospective international multi-center observational study included patients with multivessel and/or complex coronary lesions, indications for coronary revascularization and refusal of the heart team from coronary artery bypass grafting and unprotected PCI due to a high risk of complications. PCI was performed with a temporary MCS using the iVAC 2L device in five clinics in Russia and Belarus.Results. From February 2023 to February 2024, 24 patients were included in the study. The median age was 69,0 years (interquartile range (IQR): 63,5-71,8); 87,5% were men. Twenty patients (83,3%) underwent elective PCI and four patients (16,7%) due to acute coronary syndrome (ACS) as follows: three with non-ST-segment elevation myocardial infarction and one with ST-segment elevation myocardial infarction (STEMI). The patient with STEMI underwent PCI against the background of acute heart failure (AHF). The median MCS time was 66,0 min (IQR: 43,0-98,0). Technical success of PCI was achieved in 100% of patients. The median initial and residual SYNTAX scores were 35,0 (IQR: 25,6-41,4) and 8,0 (IQR: 5,0-17,5), respectively. The median left ventricular ejection fraction before PCI and 7 days after was 44,0% (IQR: 31,0-54,0) and 48,0% (IQR: 36,5-53,5), respectively. In two cases (8,3%), major bleeding from the access site of the MCS device was observed. There were 2 fatal outcomes as follows: during elective PCI due to progression of acute left ventricular failure and in the late period due to septic shock after emergency PCI.Conclusion. PCI with MCP by the iVAC 2L device is an applicable and relatively safe tactic of coronary revascularization in patients with a high risk of complications, including in the conditions of ACS and AHF.


  • Open Access

    The first experience in performing high-risk percutaneous coronary interventions using the transaortic short-term left ventricular support system PulseCath IVAC 2L

    by R.S. Tarasov, A.I. Danilovich, D.V. Pevzner, E.A. Avetisyan, V.I. Ganykov

    Первый опыт выполнения чрескожных коронарных вмешательств высокого риска с использованием трансаортальной системы кратковременной поддержки левого

  • Open Access

    Right ventricle free wall rupture during transcatheter occluder implantation in a patient with postinfarction rupture of the interventricular septum and COVID-19-associated myocarditis. Case report

    by D V Pevzner, T S Sukhinina, E N Anufriev, N S Kostritca, E A Avetisyan, V N Shitov, E V Kurilina, A G Osiev, E V Merkulov, A S Tereshchenko, et al.

    Intraventricular septum rupture is a rare mechanic complication of myocardial infarction associated with high mortality. This case describes STEMI in recovered patient after COVID 19 associated pneumonia, which was complicated by ventricular septum rupture followed by cardiogenic shock. It was managed by percutaneous occluder implantation. The procedure was complicated by right ventricular wall rupture. Postmortem examination of myocardium showed the signs of inflammation infiltrate and myocyte necrosis, according to histopathological Dallas criteria diagnosis of COVID-19 associated myocarditis was established. The COVID-19 pandemic has contributed to increasing cardiovascular mortality. This is typically attributed to diminishing resources for timely and appropriate medical care, and patients late presentations for fear of contracting the infection. Cardiovascular complication of COVID-19 may be another contributing factor. Further research is needed to improve our understanding of the mechanisms and long-term sequelae of myocardium damage in COVID-19, to optimize treatment strategy and subsequent follow-up in such patients.

  • Role of cardiac computed tomography in endovascular isolation of the left atrial appendage

    by D.V. Pevzner, E.A. Avetisyan, I.A. Merkulova, O.O. Shakhmatova, L.M. Galaeva, T.N. Veselova, M.A. Saidova, I.E. Chazova